University of Hertfordshire

Professor Darragh Murnane PhD BSc (Pharm.) MRPharmS

Professor

Expertise

Research interests

  • Inhaled drug delivery
  • In vitro product testing and modelling
  • Physical chemistry
  • Crystallization
  • Particle technology and control of the solid state
  • Industrial pharmaceutical development
  • Pharmaceutical analytical chemistry

Teaching specialisms

I have a keen interest in the teaching of science in the undergraduate pharmacy curriculum, particularly the physical pharmaceutics underpinning drug delivery. I am also interested in the development of post-graduate and vocational education for the pharmaceutical industry and have developed MSc programmes and short courses in pharmaceutics, pharmaceutical analysis and regulatory affairs. My teaching specialisms are:

  • Physical pharmaceutics
  • Manufacturing technology
  • Industrial pharmaceutics
  • Respiratory therapies
  • Drug delivery

Commercial and public engagement

Since beginning my academic career I have developed relations with a number of UK and international companies supporting internal research projects and full consultancy. I have been a member of the Royal Pharmaceutical Society Academic-Industrial Liaison Committee (2008-2010) and currently I am academic member of the Watford Chamber of Commerce Pharmaceutical Interest Network Group - a leading representation forum for the pharmaceutical industry in Hertfordshire and North London.

I currently supervise two industrially-funded research projects (Pfizer and GlaxoSmithKline). In the recent past I have cosupervised a post-doctoral fellowship funded by TEVA Pharmaceutical Industries and several short research projects with GSK, Pfizer and Melbourn Scientific. One project on which I consulted was MedPharm Ltd.'s platform technology using temperature-enhanced dermal drug delivery.

I am President of The Aerosol Society, the UK and Ireland's premier learned society for aerosol research. Working with the Past President and Education Officer, we have established a research grant scheme for young scientists with an annual fund of £15,000; increased the number of annual PhD studentships and increased our travel sponsorship. As President I play a leading role in developing a forum for knowledge exchange between academia and industry. The Society has an annual turnover of approximately £300,000 and organizes international and national conferences, including one of Europe's leading conferences, Drug Delivery to the Lungs.